Various p53-related transcriptional signatures, including the MSigDB Hallmark p53 Pathway, were upregulated in treated mice with high statistical significance in both p53+/+ and E177R, but not in p53-null leukemias (Fig. 7E and F). The gene discussed is TP53; the disease is leukemia.